Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?
TA/SARS-Cov2
1 other identifier
interventional
5
1 country
1
Brief Summary
Resident cells of human adipose tissue express ACE2 and DPP4, receptors for SARS-Cov2. The hypothesis is that the virus may enter and spread in fat depots.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 10, 2020
CompletedFirst Posted
Study publicly available on registry
June 11, 2020
CompletedStudy Start
First participant enrolled
August 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 9, 2020
CompletedJune 27, 2024
November 1, 2023
1 month
June 10, 2020
June 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The presence of SARS-CoV2 in adipose tissue of Covid19 patients
RT-qPCR for SARS-Cov-2 from RNAs and by immunodetection
Day 0
Secondary Outcomes (3)
The expression of inflammatory cytokines in adipose tissue of Covid19 patients
Day 0
The expression of inflammatory cytokines in adipose tissue of Covid19 patients
Day 0
The expression of inflammatory cytokines in adipose tissue of Covid19 patients
Day 0
Study Arms (1)
patients with Covid-19
EXPERIMENTALInterventions
Two 4mm punch biopsies of subcutaneous abdominal or thight adipose tissue
Eligibility Criteria
You may qualify if:
- Male or female ≥ 18 years old
- Patients testing positive for Covid19
- Patients affiliated to social security
- Signing of free and informed consent
You may not qualify if:
- Vulnerable persons (- minors,
- adults under guardianship or curatorship,
- pregnant women,
- persons deprived of their liberty,
- persons who do not master the French language)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nice
Nice, 06000, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2020
First Posted
June 11, 2020
Study Start
August 3, 2020
Primary Completion
September 9, 2020
Study Completion
September 9, 2020
Last Updated
June 27, 2024
Record last verified: 2023-11